Milking of the Cut-Cord During Resuscitation of Preterm Infants (The MOCC Study) (MOCC)

February 21, 2019 updated by: Walid El-Naggar, IWK Health Centre

Milking of the Cut-Cord During Resuscitation of Preterm Infants: A Randomized Controlled Trial (The MOCC Study)

In this feasibility study, the investigators will randomize preterm infants born at <32 weeks gestation to either the standard practice of delayed cord clamping (DCC) for 30-60 seconds at birth or milking of the long-cut cord (MOCC) while providing resuscitation/stabilization to the infant. The main objectives of the trial are to assess the feasibility of the new approach (MOCC) and to compare the two groups regarding the hemoglobin levels on admission to NICU in addition to neonatal morbidity and mortality.

Study Overview

Status

Recruiting

Conditions

Study Type

Interventional

Enrollment (Anticipated)

98

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

No older than 1 minute (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Preterm infants <32 weeks' gestation

Exclusion Criteria:

  • Clinical evidence of interrupted placental circulation (placental abruption or avulsed cord) or bleeding from placenta previa.
  • Monochorionic twins or any higher order multiple pregnancy
  • Major fetal congenital or chromosomal abnormality
  • Documented fetal anemia or in utero red blood cell transfusion
  • Intent to withhold or withdraw treatment of the infant

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: MOCC Group
The OB provider will hold the baby at/below the placenta, provide warmth, stimulate the baby and suction the mouth/nose for 30 secs.S/He will then clamp and cut the cord about 5 cm from the the introitus (vaginal deliveries) or from the abdominal incision (C-Sections) before handing the baby with the long-cut cord to the neonatal team to resuscitate/ stabilize the baby. A member of the neonatal team will milk the long-cut cord slowly 1 time from the cut end toward the infant over 10 secs before clamping and cutting the cord 1-2 cm from the umbilical stump. The neonatal team will provide PPV to the baby (during the milking process) if the baby is not breathing. If the baby is breathing during the milking process the team will continue the stabilization as per standard NRP practice.
After 30 seconds of DCC, the cord will be clamped and cut 5 cm from the introitus in vaginal delivery or abdominal incision in the case of cesarean section before passing the infant with the long umbilical cord segment to the pediatric provider who will milk the cord one time towards the baby during resuscitation.
Other Names:
  • Monitoring cerebral oxygenation by NIRS
Active Comparator: DCC group

The OB provider will hold the baby at or below the level of placenta, provide warmth, stimulate the baby to breathe and suction the mouth/nose if needed for the first 30 seconds.

After these initial 30 seconds, if the baby is breathing then the obstetrician will continue DCC for a total of 60 seconds before clamping and cutting the cord close to the umbilicus and handing over the baby to the neonatal team for further stabilization as per standard NRP practice. If the baby is not breathing after the initial 30 seconds of DCC, then the OB provider will clamp and cut the cord close to the umbilicus and hand over the baby to the neonatal team to continue resuscitation of the baby as per the standard NRP guidelines.

The OB provider will hold the baby at or below the level of placenta, provide warmth, stimulate the baby to breathe and suction the mouth/nose if needed for the first 30 seconds.

After these initial 30 seconds, if the baby is breathing then the obstetrician will continue DCC for a total of 60 seconds before clamping and cutting the cord close to the umbilicus and handing over the baby to the neonatal team for further stabilization as per standard NRP practice. If the baby is not breathing after the initial 30 seconds of DCC, then the OB provider will clamp and cut the cord close to the umbilicus and hand over the baby to the neonatal team to continue resuscitation of the baby as per the standard NRP guidelines.

Other Names:
  • Monitoring cerebral oxygenation by NIRS

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rate of compliance to the study intervention
Time Frame: Two years
to investigate the adherence to the new approach of MOCC during resuscitation/ stabilization following 30 seconds of DCC in preterm infants.
Two years
Number of patients completing the study
Time Frame: Two years
To evaluate the number of patients who are recruited and completed the study to estimate the sample size needed for the design of a large multi-centre RCT.
Two years
Number of adverse events associated with the MOCC intervention
Time Frame: Till the participants reach 2 year- corrected age (around 4.5 years)
To investigate any adverse events that could be attributed to the MOCC intervention.
Till the participants reach 2 year- corrected age (around 4.5 years)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Compare hemoglobin (Hgb) concentration
Time Frame: From date of randomization and assessed up to 24 hours of age
to compare hemoglobin (Hgb) concentration on NICU admission in preterm infants <32 weeks' gestation who receive MOCC during resuscitation/stabilization following 30 seconds of DCC with those who receive DCC alone for 30-60 seconds at birth (standard practice-control group).
From date of randomization and assessed up to 24 hours of age

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Temperature stability
Time Frame: From randomization assessed up to 2 hours of age
Temperature on admission to NICU
From randomization assessed up to 2 hours of age
Need for advanced resuscitation at birth
Time Frame: From randomization assessed up to 2 hours of age
Need for advanced resuscitation including intubation, chest compressions and/or medications
From randomization assessed up to 2 hours of age
Inotropic support
Time Frame: From randomization assessed up to 72 hours of age
Need for inotropic medication support
From randomization assessed up to 72 hours of age
Volume expander
Time Frame: From randomization assessed up to 72 hours of age
Assess the need for a volume expander (saline bolus or albumin bolus)
From randomization assessed up to 72 hours of age
Cerebral oxygenation
Time Frame: From randomization assessed up to 72 hours of age
Measure the cerebral oxygenation using NIRS
From randomization assessed up to 72 hours of age
Blood transfusion
Time Frame: From randomization assessed up to 36 weeks corrected gestational age
Assess the number of blood transfusions baby received from birth
From randomization assessed up to 36 weeks corrected gestational age
Intraventricular hemorrhage (IVH)
Time Frame: From randomization assessed up to 36 weeks corrected age
Assess the grade of IVH
From randomization assessed up to 36 weeks corrected age
Long-term outcomes
Time Frame: 24 Months Corrected age
Long-term neurodevelopmental outcomes at 18-24 months of corrected age.
24 Months Corrected age

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Walid El-Naggar, IWK Health Centre

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 7, 2019

Primary Completion (Anticipated)

February 7, 2021

Study Completion (Anticipated)

July 31, 2023

Study Registration Dates

First Submitted

April 30, 2018

First Submitted That Met QC Criteria

February 21, 2019

First Posted (Actual)

February 25, 2019

Study Record Updates

Last Update Posted (Actual)

February 25, 2019

Last Update Submitted That Met QC Criteria

February 21, 2019

Last Verified

February 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

IPD will not be shared

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Preterm Infant

Clinical Trials on MOCC Group

3
Subscribe